Dr. Ophir Shalem, PhD, collaborates with fellow Crazy 8 researchers in Drugging MYCN. He serves as an academic researcher for Massachusetts Institute of Technology and Investigator of Children’s Hospital of Philadelphia (CHOP), Dr. Shalem’s research focuses on translational target discovery for a range of neurogenerative diseases. He has authored 4 publications and received 681 citations for his work in CRISPR-based perturbation screens and functional genomics.